Michael Sneijers

Director at ARCHIMED
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Lyon, Auvergne-Rhône-Alpes, France, FR
Skills

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Credentials

  • Beta Gamma Sigma Honor Society Member
    Beta Gamma Sigma
    Oct, 2017
    - Oct, 2024
  • Member of the Dean's list
    IE Business School
    Jul, 2017
    - Oct, 2024

Experience

  • ArchiMed
    • France
    • Venture Capital and Private Equity Principals
    • 100 - 200 Employee
    • Director
      • Feb 2023 - Present

    • Associate Director
      • Feb 2020 - Jan 2023

    • Senior Associate
      • Jan 2019 - Jan 2020

    • Associate
      • Jan 2018 - Jan 2019

  • IE University
    • Spain
    • Education Administration Programs
    • 700 & Above Employee
    • Adjunct Professor
      • Jul 2021 - Present

  • Aliri
    • France
    • Biotechnology
    • 1 - 100 Employee
    • Board Member
      • Jun 2021 - Present

  • CLEAN BIOLOGICS
    • France
    • Biotechnology Research
    • 1 - 100 Employee
    • Board Member
      • Oct 2018 - Present

  • PMV
    • Belgium
    • Financial Services
    • 700 & Above Employee
    • Dealflow manager
      • Sep 2013 - Dec 2017

    • Senior investment manager
      • Jan 2009 - Sep 2013

  • ING Nederland
    • Netherlands
    • Banking
    • 700 & Above Employee
    • Leveraged Finance Analyst
      • Dec 2006 - Jan 2009

  • Deloitte
    • Business Consulting and Services
    • 700 & Above Employee
    • Senior Auditor
      • Sep 2003 - Feb 2006

Education

  • IE Business School
    Executive MBA
    2016 - 2017
  • CFA institute
    CFA level II candidate
    2003 - 2003
  • Universite Lille 2, Ecole Superieure des Affaires
    Master's degree
    2002 - 2003
  • KU Leuven
    Master’s degree
    1998 - 2002

Community

You need to have a working account to view this content. Click here to join now